Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis
Journal of Controlled Release · 2025-04 · 380 · 297-316
DOI: 10.1016/j.jconrel.2025.01.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-04. Verfasst von Haihua Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, PR China. Hauptthemen laut MEDLINE: Prebiotics, Probiotics, Lactiplantibacillus plantarum, beta-Glucans. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Oral administration of probiotics holds promise for alleviating ulcerative colitis (UC), yet their efficacy is inevitably compromised by the hostile gastrointestinal (GI) environment. Here, we devised a strategy by coating β-glucan (GN) prebiotic onto the surface of Lactobacillus plantarum (Lp) probiotic at the single-cell level (Lp@CGN) based on bioorthogonal chemistry in a layer-by-layer manner. This achieved to form a firm, dense, and multifunctional GN-based "armor" with advances of superior protective properties, colon-targeted degradation, and prebiotic benefits. Under the protection of the prebiotic-based "armor", Lp@CGN exhibited a notable 276-fold increase in the survival rate compared to naïve Lp after exposure to whole GI conditions. Upon reaching the colon, the "armor" was metabolized into short-chain fatty acids (SCFAs) by gut microbiota, facilitating the timely release of Lp within colon, thereby achieving a synergistic treatment effect due to sustained SCFAs generation and Lp liberation. As a result, oral administration of Lp@CGN efficiently realized the alleviation of UC in both preventative and therapeutic models through restoring intestinal mucosal barriers, positively regulating inflammatory cytokines, renovating the dysbiosis of gut microbiota, and promoting SCFAs production. In sum, our strategy marks the reconstruction of probiotics with chemical tools, offering useful insights into powering probiotics for disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, PR China.
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, PR China. Electronic address: wanhao424@ncu.edu.cn.
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, PR China. Electronic address: spnie@ncu.edu.cn.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Ji, H., Yan, X., Zhang, L., Yang, L., Xie, P., Gu, F., Bian, S., Wan, H., & Nie, S. (2025). Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis. Journal of Controlled Release, 380, 297-316. https://doi.org/10.1016/j.jconrel.2025.01.059
Vancouver
Ji H, Yan X, Zhang L, Yang L, Xie P, Gu F, et al. Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis. Journal of Controlled Release. 2025;380:297-316. doi:10.1016/j.jconrel.2025.01.059
BibTeX
@article{Ji2025,
author = {Ji, Haihua and Yan, Xiaochen and Zhang, Li and Yang, Lin and Xie, Pengcheng and Gu, Fengying and Bian, Shuigen and Wan, Hao and Nie, Shaoping},
title = {Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis},
journal = {Journal of Controlled Release},
year = {2025},
volume = {380},
pages = {297--316},
doi = {10.1016/j.jconrel.2025.01.059}
}
EUVIMED